XML 14 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
ATM program [Member]
Preferred Stock [Member]
Series A Non-Voting Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series B Non-Voting Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
ATM program [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
ATM program [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balances at Dec. 31, 2023 $ 257,802   $ 60,035   $ 86   $ 801,059   $ 246 $ (603,624)
Beginning Balances, Shares at Dec. 31, 2023     74,465   86,124,249          
Issuance of Series B Preferred Stock and common stock, net of offering costs of $11.6 million, in connection with the Private Placement 213,416     $ 87,364 $ 18   126,034      
Issuance of Series B Preferred Stock and common stock, net of offering costs of $11.6 million, in connection with the Private Placement, Shares       12,280 17,717,997          
Exchange of common stock for Series B Preferred Stock       $ 74,754 $ (8)   (74,746)      
Exchange of common stock for Series B Preferred Stock, Shares       8,300 (8,300,000)          
Issuance of common stock under Employee Stock Purchase Plan 356           356      
Issuance of common stock under Employee Stock Purchase Plan, Shares         71,150          
Unrealized losses on marketable securities (285)               (285)  
Stock-based compensation expense 9,393           9,393      
Net loss (58,348)                 (58,348)
Ending Balances at Mar. 31, 2024 422,334   $ 60,035 $ 162,118 $ 96   862,096   (39) (661,972)
Ending Balances, Shares at Mar. 31, 2024     74,465 20,580 95,613,396          
Beginning Balances at Dec. 31, 2023 257,802   $ 60,035   $ 86   801,059   246 (603,624)
Beginning Balances, Shares at Dec. 31, 2023     74,465   86,124,249          
Net loss (117,298)                  
Ending Balances at Jun. 30, 2024 373,223   $ 60,035 $ 54,085 $ 109   980,108   (192) (720,922)
Ending Balances, Shares at Jun. 30, 2024     74,465 6,868 109,343,224          
Beginning Balances at Mar. 31, 2024 422,334   $ 60,035 $ 162,118 $ 96   862,096   (39) (661,972)
Beginning Balances, Shares at Mar. 31, 2024     74,465 20,580 95,613,396          
Conversion of preferred stock into common stock       $ (107,980) $ 13   107,967      
Conversion of preferred stock into common stock, Shares       (13,712) 13,712,000          
Change in estimate on Private Placement offering costs (129)     $ (53)     (76)      
Issuance of common stock from exercises 109           109      
Issuance of common stock from exercises, Shares         17,828          
Unrealized losses on marketable securities (153)               (153)  
Stock-based compensation expense 10,012           10,012      
Net loss (58,950)                 (58,950)
Ending Balances at Jun. 30, 2024 373,223   $ 60,035 $ 54,085 $ 109   980,108   (192) (720,922)
Ending Balances, Shares at Jun. 30, 2024     74,465 6,868 109,343,224          
Beginning Balances at Dec. 31, 2024 256,286   $ 56,515 $ 54,085 $ 110   1,004,612   447 (859,483)
Beginning Balances, Shares at Dec. 31, 2024     70,465 6,868 110,461,729          
Issuance of common stock, net of issuance costs   $ 24,250       $ 3   $ 24,247    
Issuance of common stock, net of issuance costs, Shares           2,587,992        
Conversion of preferred stock into common stock     $ (2,435)   $ 1   2,434      
Conversion of preferred stock into common stock, Shares     (2,767)   691,750          
Issuance of common stock from exercises 136           136      
Issuance of common stock from exercises, Shares         26,842          
Issuance of common stock under Employee Stock Purchase Plan 584           584      
Issuance of common stock under Employee Stock Purchase Plan, Shares         88,141          
Unrealized losses on marketable securities (283)               (283)  
Stock-based compensation expense 10,008           10,008      
Net loss (71,986)                 (71,986)
Ending Balances at Mar. 31, 2025 218,995   $ 54,080 $ 54,085 $ 114   1,042,021   164 (931,469)
Ending Balances, Shares at Mar. 31, 2025     67,698 6,868 113,856,454          
Beginning Balances at Dec. 31, 2024 256,286   $ 56,515 $ 54,085 $ 110   1,004,612   447 (859,483)
Beginning Balances, Shares at Dec. 31, 2024     70,465 6,868 110,461,729          
Net loss (145,515)                  
Ending Balances at Jun. 30, 2025 155,036   $ 53,830 $ 54,085 $ 114   1,051,992   13 (1,004,998)
Ending Balances, Shares at Jun. 30, 2025     67,414 6,868 113,928,492          
Beginning Balances at Mar. 31, 2025 218,995   $ 54,080 $ 54,085 $ 114   1,042,021   164 (931,469)
Beginning Balances, Shares at Mar. 31, 2025     67,698 6,868 113,856,454          
Conversion of preferred stock into common stock     $ (250)       250      
Conversion of preferred stock into common stock, Shares     (284)   71,000          
Issuance of common stock from exercises 5           5      
Issuance of common stock from exercises, Shares         1,038          
Unrealized losses on marketable securities (151)               (151)  
Stock-based compensation expense 9,716           9,716      
Net loss (73,529)                 (73,529)
Ending Balances at Jun. 30, 2025 $ 155,036   $ 53,830 $ 54,085 $ 114   $ 1,051,992   $ 13 $ (1,004,998)
Ending Balances, Shares at Jun. 30, 2025     67,414 6,868 113,928,492